Risk-Benefit Analysis in Drug Research : Proceedings of an International Symposium Held at the University of Kent at Canterbury, England, 27 March 1980
معرفی کتاب «Risk-Benefit Analysis in Drug Research : Proceedings of an International Symposium Held at the University of Kent at Canterbury, England, 27 March 1980» نوشتهٔ Sir Edward E. Pochin (auth.), Dr. J. F. Cavalla (eds.)، منتشرشده توسط نشر Springer Netherlands : Imprint : Springer در سال 1981. این کتاب در فرمت pdf، زبان انگلیسی ارائه شده است.
The appreciation of risk like the awareness of beauty lies very much in the eyes of the beholder. It involves a value judgement and can never be absolute. Yet paradoxically, modern society is demanding ever greater degrees of safety in the medicines it takes, to the extent that nothing short of the total absence of risk will be tolerated. Since 1960, and mainly as a result of the thalidomide tragedy, governmental regulation of testing and use of new medicines has grown apace throughout the world. It has derived impetus not only from the understandable wish of the public to seek protection, but also from the anxiety of bureaucrats and politicians not to be seen to have made mistakes. Both these concerns have been inflamed by the recognition of the media that all drugs make news and horror drugs make the best news of all. Prior to this time the physician and his cures enjoyed a relatively supportive public. It was true that quacks existed and were recognized as such but, in the main, people wanted to take medicines and expected them to do them good. Front Matter....Pages i-x Risk-benefit in medicine....Pages 1-16 The effect on industry....Pages 17-25 The effect on the public....Pages 27-42 The necessary role of government....Pages 43-49 Problems facing a regulatory authority....Pages 51-66 The effect on pharmaceutical research....Pages 67-73 New-drug assessment in man: a clinical pharmacologist’s view....Pages 75-92 The effect on choice of research....Pages 93-95 The relative worth of animal testing....Pages 97-112 The prospect of product liability....Pages 113-130 The effect on world medicine....Pages 131-134 Preclinical requirements....Pages 135-140 Post-marketing drug surveillance....Pages 141-161 The influence of the media....Pages 163-177 The influence of the medical profession....Pages 179-184 Summary and Conclusions....Pages 185-190 Back Matter....Pages 191-197
دانلود کتاب Risk-Benefit Analysis in Drug Research : Proceedings of an International Symposium Held at the University of Kent at Canterbury, England, 27 March 1980